Dow Down0.02% Nasdaq Up0.07%

Array BioPharma, Inc. (ARRY)

-NGM
3.92 Up 0.02(0.51%) Nov 25, 4:00PM EST
|After Hours : 3.92 Down 0.00 (0.01%) Nov 25, 4:35PM EST
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Jun 30, 2013Jun 30, 2012
Net Income (85,257) (61,942) (23,581)
Operating Activities, Cash Flows Provided By or Used In
Depreciation4,506  4,350  5,076  
Adjustments To Net Income5,089  21,979  9,905  
Changes In Accounts Receivables4,166  (8,520)1,157  
Changes In Liabilities5,420  (38,699)(23,815)
Changes In Inventories -   -   -  
Changes In Other Operating Activities(5,606)(4,235)(2,288)
Total Cash Flow From Operating Activities (71,682) (87,067) (33,546)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(2,614)(2,340)(1,437)
Investments5,096  (14,022)(17,284)
Other Cash flows from Investing Activities -   -   -  
Total Cash Flows From Investing Activities 2,482   (16,362) (18,721)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock77,141  73,016  64,317  
Net Borrowings -  39,538  (4,350)
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 77,055   108,366   59,967  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents 7,855   4,937   7,700  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.